LEVIvs its industry peers
A metric-by-metric comparison of LEVI against SIC 2300 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LEVI본 종목 | — | 15.0x#1 | — | — | 4.1%#6 | 174.5%#3 | 10.8%#2 | 25.4%#1 | 20.0%#1 | — | — | — |
| JRSH | $75M#4 | 16.0x#2 | 1.1x#1 | 0.5x#2 | 14.0%#2 | 531.9%#2 | 3.8%#4 | 5.5%#4 | 8.3%#2 | — | — | 3.4%#2 |
| PMNT | $9M#7 | — | — | 0.4x#1 | 9.8%#5 | 55.3%#4 | -22.2%#6 | — | — | — | — | — |
| BIRD | — | — | — | — | -19.7%#7 | 17.2%#5 | -52.4%#7 | -343.1%#6 | -3088.5%#4 | — | -77.1%#1 | — |
| BRIA | $35M#5 | — | — | 0.5x#3 | 15.1%#1 | -14.2%#7 | — | — | — | — | — | 9.1%#1 |
| FIGS | $3.5B#2 | 64.6x#3 | 8.0x#4 | 5.6x#6 | 13.6%#3 | 1170.4%#1 | 6.0%#3 | 7.8%#3 | — | — | — | — |
| GIL | $7.3B#1 | — | 2.1x#3 | 2.0x#5 | 10.7%#4 | -0.5%#6 | 17.1%#1 | 11.2%#2 | — | — | — | 1.8%#3 |
| LANV | $103M#3 | — | — | — | — | — | — | — | — | — | — | — |
| NCI | $14M#6 | 70.3x#4 | 2.0x#2 | 0.8x#4 | -41.9%#8 | -95.9%#8 | 1.3%#5 | 0.6%#5 | 0.5%#3 | 6#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2300). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice